Skip to main content
PIII logo

P3 Health Partners Inc. (PIII) Stock: Price, Forecast & Analyst Target

P3 Health Partners Inc. (PIII) — MoonshotScore 31/100 (Weak band), calculated Nov 18, 2026. Price $1.86 (-13.49%), as of the Nov 19, 2026 trading session.

Educational signal · not a buy or sell recommendation · How to read this

$1.86 −$0.29 (-13.49%)

P3 Health Partners Inc. · PIII · NASDAQ

is a physician-led population health management enterprise headquartered in Henderson, Nevada, focusing on delivering patient-centered, value-based care across the United States. The company partners with independent physician groups to improve care coordination, primarily for seniors, within a network of clinics and wellness centers.

Price as of Nov 19, 2026

Key Statistics

31 of 100

MoonshotScore v2 · P3 Health Partners (PIII)

Weak
Business Quality Elite (84)
Financial Safety Fragile (6)
Valuation Full (42)
Growth Durability Flat (41)
Momentum Falling (17)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality, but a fragile balance sheet and a full valuation, and the price trend has turned against it. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Elite; Financial Safety: Fragile; Valuation: Full; Growth Durability: Flat; Momentum: Falling.

  • quarterly revenue $386M (Q2 FY2026, quarter ended Jun 30, 2026)
  • EPS beat 2 of the last 8 reports
  • Altman Z 0.27 · Piotroski F 3

Holding back: balance-sheet strain, weak price trend

Helping: business quality

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for PIII (57 recorded, newest six shown)
RecordedScoreBand
29Weak
30Weak
29Weak
29Weak
31Weak
31Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

As of
MeasureValue
Latest provided price$1.86
Change on the day-13.49%
Shares traded on the day44.7K

Price & events

Other perspectives

Council score for P3 Health Partners (PIII): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Strong
Financial Safety Negative
Valuation Neutral
Growth Durability Neutral
Momentum Negative

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Nov 13, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Undervalued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Negative
ROE Strong
Gross Margin Neutral

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is P3 Health Partners (PIII), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. P3 Health Partners Inc. (PIII) is listed on NASDAQ. It employs 320 people. In Q2 FY2026 it reported revenue of $386M and net income of $7M.

2 · Latest results

What do the latest results show for P3 Health Partners (PIII)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $386M. Against analyst estimates the company has EPS beat 2 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$386M$7M-$0.63 (diluted)
Q1 FY2026$386M$1M$0.37 (diluted)
Q4 FY2025$385M-$76M-$23.02 (diluted)
Q3 FY2025$345M-$32M-$9.67 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for P3 Health Partners (PIII)?

Short answer · as of

The MoonshotScore pillars rate business quality as strengths. What is holding it back is balance-sheet strain, weak price trend. The distress and quality screens read Altman Z 0.27 · Piotroski F 3. Trailing ratios: ROE 171.7% · ROA -7.6% · current ratio 0.53.

Data-derived red flags

  • Financial-distress signal — its Altman Z-Score of 0.27 sits in the distress zone (elevated bankruptcy risk).
  • Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
4 · What to check next?

What should you watch next at P3 Health Partners (PIII)?

Short answer · as of

Current published price targets run low $23.00 · high $23.00 · consensus $23.00 · median $23.00 against a quoted price of $1.86 (as of Nov 19, 2026).

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does P3 Health Partners compare with its peers?

Short answer

P3 Health Partners's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Tenet Healthcare Corporation (THC) Same industry, near in market value$263.59 Nov 19, 2026$21.0B94 5-pillar Nov 18, 2026
LifeStance Health Group, Inc. (LFST) Same industry, near in market value$13.77 Nov 18, 2026$5.24B92 5-pillar Nov 18, 2026
Universal Health Services, Inc. (UHS) Same industry, near in market value$186.07 Nov 18, 2026$10.7B91 5-pillar Nov 18, 2026
Chemed Corporation (CHE) Same industry, near in market value$551.33 Nov 19, 2026$7.15B85 5-pillar Nov 18, 2026
Option Care Health, Inc. (OPCH) Same industry, near in market value$31.61 Nov 19, 2026$4.74B85 5-pillar Nov 18, 2026
Encompass Health Corporation (EHC) Same industry, near in market value$132.25 Nov 19, 2026$13.0B81 5-pillar Nov 18, 2026
Fresenius Medical Care AG & Co. KGaA (FMS) Same industry, near in market value$20.13 Nov 19, 2026$10.5B80 5-pillar Nov 18, 2026
HCA Healthcare, Inc. (HCA) Same industry, near in market value$476.35 Nov 18, 2026$99.5B77 5-pillar Nov 18, 2026
DaVita Inc. (DVA) Same industry, near in market value$156.24 Nov 19, 2026$9.83B76 5-pillar Nov 18, 2026
National HealthCare Corporation (NHC) Same industry, near in market value$201.60 Nov 18, 2026$3.16B76 5-pillar Nov 18, 2026
The Ensign Group, Inc. (ENSG) Same industry, near in market value$176.59 Nov 19, 2026$10.3B74 5-pillar Nov 18, 2026
Solventum Corporation (SOLV) Same industry, near in market value$85.80 Nov 19, 2026$14.6B66 5-pillar Nov 18, 2026
P3 Health Partners (PIII) — this page$1.86—31

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$23.00 – $23.00
Consensus target
$23.00
Median target
$23.00

Consensus record · Captured .

Measured against a quoted price of $1.86 (as of Nov 19, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Aug 13, 2026

Transactions
9
Identified insiders
1
Purchases
0
Sales
3
Other transactions
6

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held PIII in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported PIII in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about P3 Health Partners (PIII)?

Read these with our analysis →

What Investors Ask About P3 Health Partners (PIII)

These answers are editorial: they are written from question templates that restate figures shown above. They are not part of the source register.

What does the MoonshotScore mean for PIII?

PIII carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is PIII a good stock to buy?

Stock Expert AI does not rate PIII buy, sell or hold. P3 Health Partners Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the PIII stock price today?

The last price recorded for P3 Health Partners Inc. (PIII), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the PIII price target?

The analyst consensus price target for P3 Health Partners Inc. (PIII), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What are the key factors to evaluate for PIII?

(PIII) holds a MoonshotScore in the low range. To weigh it, read the analyst view under Analyst targets & estimates on this page. Not financial advice.

How frequently does PIII data refresh on this page?

PIII's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven PIII's recent stock price performance?

(PIII) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Physician-led and patient-centered approach to healthcare delivery. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider PIII overvalued or undervalued right now?

(PIII) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Its analyst consensus target is listed under Analyst targets & estimates on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of PIII?

Fractional-share availability for P3 Health Partners Inc. (PIII) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 17 figures on this page — 13 from Financial Modeling Prep (FMP), 3 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.